Gene · 10818
Papers1,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FGFR1 Inhibition by Pemigatinib Enhances Radiosensitivity in Glioblastoma Stem Cells Through S100A4 Downregulation. | Cells | 2025 | 41002392 | PubTator, text mining | PubMed |
| Claudin-1 Contributes to Gastrointestinal Stromal Tumors (GIST) Resistance to Imatinib Mesylate (IM) via Regulation of FGFR-Signaling. | Int J Mol Sci | 2025 | 40943068 | PubTator, text mining | PubMed |
| Genetic Architecture of Ischemic Stroke: Insights from Genome-Wide Association Studies and Beyond. | J Cardiovasc Dev Dis | 2025 | 40863347 | PubTator, text mining | PubMed |
| The Dark Side of Vascular Aging: Noncoding Ribonucleic Acids in Heart Failure with Preserved Ejection Fraction. | Cells | 2025 | 40862748 | PubTator, text mining | PubMed |
| Study on differentially expressed genes and pattern recognition receptors in osteoporosis based on bioinformatics analysis. | Sci Rep | 2025 | 40854963 | PubTator, text mining | PubMed |
| Generation of human induced pluripotent stem cell lines from patients with FGFR2-linked syndromic craniosynostosis. | Dis Model Mech | 2025 | 40843495 | PubTator, text mining | PubMed |
| miR-590-5p mediates mitochondrial respiration, proliferation, and apoptosis in thyroid carcinoma cells via fibroblast growth factor receptor substrate 2. | Arch Endocrinol Metab | 2025 | 40834280 | PubTator, text mining | PubMed |
| Role of NTRK Fusion Genes in the Tumor Immune Microenvironment of HPV (+/-) Cervical Cancer. | J Med Virol | 2025 | 40832845 | PubTator, text mining | PubMed |
| Dedifferentiated liposarcoma with low-grade fibromyxoid sarcoma and inflammatory myofibroblastic tumor: A case report and literature review. | Medicine (Baltimore) | 2025 | 40826716 | PubTator, text mining | PubMed |
| Osteoblasts sense extracellular levels of phosphate to control the local expression of phosphatases for matrix mineralisation. | Bone Rep | 2025 | 40791815 | PubTator, text mining | PubMed |
| Droplet digital PCR assay for precise determination of FRS2 gene copy number in bladder cancer. | BMC Cancer | 2025 | 40707918 | PubTator, text mining | PubMed |
| Oncogenic and Immunological Roles of FRS2 and its Potential Value in Retroperitoneal Liposarcoma: from Bioinformatics Analysis to Clinicopathological Evidence. | Int J Med Sci | 2025 | 40225873 | PubTator, text mining | PubMed |
| Unveiling an unexpected redox regulation of the folding, function and inhibition in the phosphotyrosine binding domain of FRS2. | Int J Biol Macromol | 2025 | 40203902 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| [Alveolar rhabdomyosarcoma with amplification of 12q15 region including MDM2 and FRS2 genes: report of a case]. | Zhonghua Bing Li Xue Za Zhi | 2025 | 39762180 | PubTator, text mining | PubMed |
| Shc1 cooperates with Frs2 and Shp2 to recruit Grb2 in FGF-induced lens development. | bioRxiv | 2025 | 39484547 | PubTator, text mining | PubMed |
| Decoding FGF/FGFR Signaling: Insights into Biological Functions and Disease Relevance. | Biomolecules | 2024 | 39766329 | PubTator, text mining | PubMed |
| Retraction Note: MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms' tumor via targeting FRS2. | Eur Rev Med Pharmacol Sci | 2024 | 39497592 | PubTator, text mining | PubMed |
| Genetic Mechanisms Involved in Microbial Stress Responses. | Genes (Basel) | 2024 | 39457389 | PubTator, text mining | PubMed |
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort. | Arthritis Res Ther | 2024 | 39342401 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10818/papers?page=2